What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Immune system
Giulio C. Spagnoli mainly focuses on Immunology, Molecular biology, Antigen, Cytotoxic T cell and Pathology.
His studies in Molecular biology integrate themes in fields like Gene product, Gene expression, Cell growth, Antigen-presenting cell and Melanoma.
His Antigen research is multidisciplinary, incorporating elements of Immunotherapy, Cancer immunotherapy and Antigen presentation.
His research integrates issues of Cell culture and T cell, Dendritic cell, Immune system in his study of Cytotoxic T cell.
His research in Pathology intersects with topics in Epitope, Colorectal cancer and CD8.
His CD8 research focuses on Cancer research and how it relates to Arginase.
His most cited work include:
- Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells. (334 citations)
- Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints (302 citations)
- Clinical impact of programmed cell death ligand 1 expression in colorectal cancer. (275 citations)
What are the main themes of his work throughout his whole career to date?
Giulio C. Spagnoli focuses on Antigen, Immunology, Cytotoxic T cell, Pathology and Cancer research.
His biological study deals with issues like Monoclonal antibody, which deal with fields such as T-cell receptor.
His Immunology research includes elements of Peripheral blood mononuclear cell and Melanoma.
He has researched Cytotoxic T cell in several fields, including Molecular biology, Cell culture, CD8 and T cell.
His biological study spans a wide range of topics, including Cancer, Cancer/testis antigens and In vivo.
His Cancer research study incorporates themes from Cancer cell, Cell, Colorectal cancer and Mesenchymal stem cell.
He most often published in these fields:
- Antigen (30.47%)
- Immunology (29.39%)
- Cytotoxic T cell (27.24%)
What were the highlights of his more recent work (between 2013-2021)?
- Cancer research (25.09%)
- Colorectal cancer (13.62%)
- Pathology (25.81%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Cancer research, Colorectal cancer, Pathology, Cancer and Immunology.
His Cancer research research incorporates elements of Cancer cell, Cell, Apoptosis and In vivo.
His studies deal with areas such as Mesenchymal stem cell, CD8, Immune system and Oncology as well as Colorectal cancer.
His Pathology research is multidisciplinary, relying on both Tumor progression, Perfusion bioreactor, Biomedical engineering and Primary breast cancer.
Many of his studies on Immunology apply to Cytotoxic T cell as well.
He interconnects CXCL10 and Cell culture in the investigation of issues within Cytotoxic T cell.
Between 2013 and 2021, his most popular works were:
- Microtubule-Depolymerizing Agents Used in Antibody–Drug Conjugates Induce Antitumor Immunity by Stimulation of Dendritic Cells (81 citations)
- Gut microbiota modulate T cell trafficking into human colorectal cancer (75 citations)
- The Interplay Between Neutrophils and CD8+ T Cells Improves Survival in Human Colorectal Cancer. (69 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Immune system
His main research concerns Cancer research, Pathology, Cancer, Immunology and Cytotoxic T cell.
His Cancer research study combines topics from a wide range of disciplines, such as Cell, Cancer cell, Transcriptome, Downregulation and upregulation and In vivo.
His research in Pathology intersects with topics in Head and neck squamous-cell carcinoma, Head and neck cancer, Colorectal cancer and NY-ESO-1.
His Cancer/testis antigens and Tumor microenvironment study, which is part of a larger body of work in Cancer, is frequently linked to Indoleamine 2,3-dioxygenase, bridging the gap between disciplines.
Immunology and Cell biology are commonly linked in his work.
His study looks at the relationship between Cytotoxic T cell and fields such as T cell, as well as how they intersect with chemical problems.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
